$BCDA· SEC filing ·

BCDA Reports Q1 2026 Net Loss $2.3M, Cash $0.95M

BioCardia, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $0.92

-11% in 1d after detection

Post-detection moves

1h
1d
-11%
3d
-8.9%
7d
-11%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS